Pilot association study of the β-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity

Movement Disorders

Volumn 20, Issue 1, 2005, Pages 100-103

  Clark, Lorraine N ^a,b   Nicolai, Angelique ^b   Afridi, Shehla ^a   Harris, Juliette ^b   Mejia Santana, Helen ^c   Strug, Lisa ^d   Cote, Lucien J ^b,c   Louis, Elan D ^b,c   Andrews, Howard ^b   Waters, Cheryl ^b   Ford, Blair ^b   Frucht, Steven ^b   Fahn, Stanley ^b   Mayeux, Richard ^a,b,c   Ottman, Ruth ^c,d,e   Marder, K ^a,b,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b New York State Psychiatric Institute ^*  (United States)

^c Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^d NONE   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Beta glucocerebrosidase; Genetic risk factor; Heterozygote; Homozygote; Jewish ethnicity; N370S

Indexed keywords

BETA GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNOLOGY; FEMALE; GAIT DISORDER; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; MUSCLE RIGIDITY; PARKINSON DISEASE; PILOT STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREMOR;

AGED; ALLELES; ASPARTIC ACID; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCOSYLCERAMIDASE; HUMANS; JEWS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PARKINSON DISEASE; PILOT PROJECTS; POINT MUTATION; SERINE;

EID: 14044262300     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20320     Document Type: Article

References (29)

1. Marks DL, Pagano RE. Endocytosis and sorting of glycosphingolipids in sphingolipid storage disease. Trends Cell Biol 2002;12: 605-613.
2. Charrow J, Andersson HC, Kaplan P, et al. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med 2000;160:2835-2843.
3. Knudsen A, Kaplan W. Genetics of sphingolipidosis. In: Aranson S, Volk B, editors. Cerebral sphingolipidosis. New York: Academic Press; 1962. p 395-411.
4. Miller JD, McCluer R, Kanfer JN. Gaucher's disease: neurologic disorder in adult siblings. Ann Intern Med 1973;78:883-887.
5. King JO. Progressive myoclonic epilepsy due to Gaucher's disease in an adult. J Neurol Neurosurg Psychiatry 1975;38:849-854.
6. Neil JF, Glew RH, Peters SP. Familial psychosis and diverse neurologic abnormalities in adult-onset Gaucher's disease. Arch Neurol 1979;36:95-99.
7. McKeran RO, Bradbury P, Taylor D, Stern G. Neurological involvement in type 1 (adult) Gaucher's disease. J Neurol Neurosurg Psychiatry 1985;48:172-175.
8. Neudorfer O, Giladi N, Elstein D, et al. Occurrence of Parkinson's syndrome in type I Gaucher disease. Q J Med 1996;89:691-694.
9. Tayebi N, Callahan M, Madike V, et al. Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab 2001;73:313-321.
10. Guimaraes J, Amaral O, Sa Miranda MC. Adult-onset neuronopathic form of Gaucher's disease: a case report. Parkinsonism Relat Disord 2003;9:261-264.
11. Park JK, Orvisky E, Tayebi N, et al. Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup. Pediatr Res 2003;53:387-395.
12. Cormand B, Grinberg D, Gort L, et al. Molecular analysis and clinical findings in the Spanish Gaucher disease population: putative haplotype of the N370S ancestral chromosome. Hum Mutat 1998;11:295-305.
13. Machaczka M, Rucinska M, Skotnicki AB, Jurczak W. Parkinson's syndrome preceding clinical manifestation of Gaucher's disease. Am J Hematol 1999;61:216-217.
14. Tayebi N, Walker J, Stubblefield B, et al. Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 2003;79:104-109.
15. Varkonyi J, Rosenbaum H, Baumann N, et al. Gaucher disease associated with parkinsonism: four further case reports. Am J Med Genet 2003;116A:348-351.
16. Pastores GM, Barnett NL, Bathan P, Kolodny EH. A neurological symptom survey of patients with type I Gaucher disease. J Inherit Metab Dis 2003;26:641-645.
17. Lwin AA, Orvisky E, Eblan M, Sidransky E. Glucocerebrosidase mutations in subjects with Parkinson's disease. Am J Hum Genet 2003;S73:2115.
18. Lwin A, Orvisky E, Goker-Alpan O, et al. Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab 2004; 81:70-73.
19. Ostrer H. A genetic profile of contemporary Jewish populations. Nat Rev Genet 2001;2:891-898.
20. Stone DL, Tayebi N, Orvisky E, et al. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum Mutat 2000;15:181-188.
21. Marder K, Levy G, Louis ED, et al. Familial aggregation of early-and late-onset Parkinson's disease. Ann Neurol 2003;54:507-513.
22. Hughes AJ Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
23. Tang MX, Stern Y, Marder K, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 1998;279:751-755.
24. Fahn S, Marsden CD, Calne D. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Healthcare Information; 1987.
25. Stern Y, Sano M, Paulson J, Mayeux R. Modified mini-mental state examination: validity and reliability. Neurology 1987; 37(Suppl. 1):179.
26. Zimran A, Gelbart T, Westwood B, et al. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. Am J Hum Genet 1991;49:855-859.
27. Beutler E, Gelbart T, West C. Identification of six new Gaucher disease mutations. Genomics 1993;15:203-205.
28. Mateu E, Perez-Lezaun A, Martinez-Arias R, et al. PKLR- GBA region shows almost complete linkage disequilibrium over 70 kb in a set of worldwide populations. Hum Genet 2002;110:532-544.
29. Marder K, Levy G, Louis ED, et al. Accuracy of family history data on Parkinson's disease. Neurology 2003;61:18-23.